StreetInsider.com News Articles

Form 4 PTC THERAPEUTICS, INC. For: Jul 14 Filed by: Gravier Pierre

Thu, 16 Jul 2026 17:20:00 -0400

si-local-file:///var/storage/secattach/20260716/26780645.html

Form 4 PTC THERAPEUTICS, INC. For: Jul 14 Filed by: Gravier Pierre

Thu, 16 Jul 2026 17:20:00 -0400

si-local-file:///var/storage/secattach/20260716/26780645.html

PTC Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, July 30, 2026

Thu, 16 Jul 2026 08:00:00 -0400

WARREN, N.J., July 16, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the company will host a webcast conference call to report its second quarter 2026 financial results and provide an update on the company's business and outlook on Thursday, July 30, 2026, at 4:30 p.m. ET.

PTC Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, July 30, 2026

Thu, 16 Jul 2026 08:00:00 -0400

PTC Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, July 30, 2026

Thu, 16 Jul 2026 08:00:00 -0400

PTC Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, July 30, 2026

Thu, 16 Jul 2026 08:00:00 -0400

PTC Therapeutics (PTCT) PT Raised to $130 at Cantor Fitzgerald on PKU Launch

Thu, 16 Jul 2026 07:23:31 -0400

Cantor Fitzgerald analyst Kristen Kluska raised the price target on PTC Therapeutics (NASDAQ: PTCT) to $130.00 (from $124.00) while maintaining a Overweight rating.

The analyst commented, "The top inbound we get from investors is how to think about PTCT's valuation, which has become even more topical following the company reaching its 52-week highs this month. With this report, we also newly incorporated a Japanese market model for Sephience, which leads to our new PT of $130 from $124. Given the strength of the Sephience (PKU) launch and more votoplam (oral splicing modulator for Huntington's disease) PIVOT-HD data, we evaluated how various

PTC Therapeutics (PTCT) PT Raised to $130 at Cantor Fitzgerald on PKU Launch

Thu, 16 Jul 2026 07:23:31 -0400

Cantor Fitzgerald analyst Kristen Kluska raised the price target on PTC Therapeutics (NASDAQ: PTCT) to $130.00 (from $124.00) while maintaining a Overweight rating.

PTC Therapeutics (PTCT) Reiterated at Overweight by Cantor Fitzgerald

Wed, 15 Jul 2026 07:51:27 -0400

Cantor Fitzgerald analyst Kristen Kluska reiterated an Overweight rating and $124.00 price target on PTC Therapeutics (NASDAQ: PTCT).

The analyst commented, "The Sephience (cofactor therapy) launch for PKU (rare inherited metabolic disorder) has been off to a very strong start, and 6 July 14, 2026 every quarter we learn more and more about the potential. Meet with management to better understand all the nuances of the launch and global expansion, and ultimately how this should influence peak sales. We also believe NVS (NC) and PTC could be in a position to discuss the latest on potential FDA dialogue for votoplam (oral

Form 144 PTC THERAPEUTICS, INC. Filed by: Gravier Pierre

Tue, 14 Jul 2026 15:14:00 -0400

si-local-file:///var/storage/secattach/20260714/26767915.html

Form 144 PTC THERAPEUTICS, INC. Filed by: Gravier Pierre

Tue, 14 Jul 2026 15:14:00 -0400

si-local-file:///var/storage/secattach/20260714/26767915.html

Form 4 PTC THERAPEUTICS, INC. For: Jul 09 Filed by: Smith Mary L.

Mon, 13 Jul 2026 17:20:00 -0400

si-local-file:///var/storage/secattach/20260713/26763250.html

Form 4 PTC THERAPEUTICS, INC. For: Jul 09 Filed by: Smith Mary L.

Mon, 13 Jul 2026 17:20:00 -0400

si-local-file:///var/storage/secattach/20260713/26763250.html

Form 4 PTC THERAPEUTICS, INC. For: Jul 09 Filed by: Almstead Neil Gregory

Mon, 13 Jul 2026 17:20:00 -0400

si-local-file:///var/storage/secattach/20260713/26763254.html

Form 4 PTC THERAPEUTICS, INC. For: Jul 09 Filed by: Almstead Neil Gregory

Mon, 13 Jul 2026 17:20:00 -0400

si-local-file:///var/storage/secattach/20260713/26763254.html

Form 144 PTC THERAPEUTICS, INC. Filed by: Almstead Neil Gregory

Thu, 09 Jul 2026 16:12:00 -0400

si-local-file:///var/storage/secattach/20260709/26753324.html

Form 144 PTC THERAPEUTICS, INC. Filed by: Almstead Neil Gregory

Thu, 09 Jul 2026 16:12:00 -0400

si-local-file:///var/storage/secattach/20260709/26753324.html

Form 144 PTC THERAPEUTICS, INC. Filed by: Smith Mary L.

Thu, 09 Jul 2026 12:19:00 -0400

si-local-file:///var/storage/secattach/20260709/26752188.html

Form 144 PTC THERAPEUTICS, INC. Filed by: Smith Mary L.

Thu, 09 Jul 2026 12:19:00 -0400

si-local-file:///var/storage/secattach/20260709/26752188.html

Form 4 PTC THERAPEUTICS, INC. For: Jul 06 Filed by: Almstead Neil Gregory

Wed, 08 Jul 2026 17:20:00 -0400

si-local-file:///var/storage/secattach/20260708/26748377.html

Form 4 PTC THERAPEUTICS, INC. For: Jul 06 Filed by: Almstead Neil Gregory

Wed, 08 Jul 2026 17:20:00 -0400

si-local-file:///var/storage/secattach/20260708/26748377.html

Form 4 PTC THERAPEUTICS, INC. For: Jul 06 Filed by: Boulding Mark Elliott

Wed, 08 Jul 2026 17:20:00 -0400

si-local-file:///var/storage/secattach/20260708/26748378.html

Form 4 PTC THERAPEUTICS, INC. For: Jul 06 Filed by: Boulding Mark Elliott

Wed, 08 Jul 2026 17:20:00 -0400

si-local-file:///var/storage/secattach/20260708/26748378.html

Form 144 PTC THERAPEUTICS, INC. Filed by: Almstead Neil Gregory

Tue, 07 Jul 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260707/26741902.html

Form 144 PTC THERAPEUTICS, INC. Filed by: Almstead Neil Gregory

Tue, 07 Jul 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260707/26741902.html